FibroBiologics

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. 4 March 2025 -- Texas, US -- FibroBiologics, Inc, a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived...
455 E. Medical Center Blvd. Suite 300 Houston, TX 77598

(281) 671-5150